Modification of the vaccine manufacturing process improves the pyrogenicity profile of inactivated influenza vaccines in young children.

CONCLUSION: This analysis provides clinical evidence that the modified manufacturing process improved the fever profile across all pediatric age groups, in particular, in children aged <5 years. PMID: 30935743 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research